Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Lars Fruergaard Jørgensen
CEOLars Fruergaard Jørgensen
Employees
76,302
Employees76,302
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1931
Founded1931
Employees
76,302
Employees76,302

NVO Key Statistics

Market cap
300.70B
Market cap300.70B
Price-Earnings ratio
19.84
Price-Earnings ratio19.84
Dividend yield
1.76%
Dividend yield1.76%
Average volume
12.99M
Average volume12.99M
High today
$70.00
High today$70.00
Low today
$67.65
Low today$67.65
Open price
$69.45
Open price$69.45
Volume
12.56M
Volume12.56M
52 Week high
$148.15
52 Week high$148.15
52 Week low
$57.00
52 Week low$57.00

NVO News

CNBC 2d
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly

In this article NOVO.B-DK Follow your favorite stocks CREATE FREE ACCOUNT A view of the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outsk...

Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Sherwood News 2d
Europe’s most valuable company, SAP, is only extending its lead

The German software giant has seen its market cap skyrocket on the back of US tariffs — the same can’t be said for Novo Nordisk and LVMH. Since dethroning Novo...

Europe’s most valuable company, SAP, is only extending its lead
TipRanks 4d
Sector Spotlight: Trump executive order targets drug prices

Welcome to the latest edition of “Sector Spotlight,” where The Fly looks at a new industry every week and highlights its happenings. Confident Investing Starts...

Analyst ratings

61%

of 31 ratings
Buy
61.3%
Hold
29%
Sell
9.7%

More NVO News

Barchart 4d
Is Novo Nordisk Stock A Buy, Sell, Or Hold As CEO Lars Fruergaard Jørgensen Resigns? - Barchart.com

...

Is Novo Nordisk Stock A Buy, Sell, Or Hold As CEO Lars Fruergaard Jørgensen Resigns? - Barchart.com
Seeking Alpha 5d
Eli Lilly, compounders partly to blame for Novo CEO’s ouster

Novo Nordisk (NVO) (OTCPK:NONOF) appears to have forced its CEO, Lars Fruergaard Jørgensen, to resign as the Danish pharma giant grapples with the rising domina...

Eli Lilly, compounders partly to blame for Novo CEO’s ouster
TipRanks 5d
Novo Nordisk Ousts CEO After 50% Drop in NVO Stock

Novo Nordisk (NVO) CEO Lars Fruergaard Jørgensen will step down from the global healthcare company after eight years as it seeks a new leader. Jørgensen’s depar...

TipRanks 5d
Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Market Challenges

Confident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive underval...

Benzinga 5d
Ozempic Maker Novo Nordisk Looks For New Chief, Jørgensen Steps Down From CEO Role

Novo Nordisk A/S NVO shares fell on Friday after the company announced that CEO Lars Fruergaard Jørgensen will step down after eight years leading the company....

Ozempic Maker Novo Nordisk Looks For New Chief, Jørgensen Steps Down From CEO Role
Axios 5d
Wegovy maker Novo Nordisk CEO to step down - Axios

...

Wegovy maker Novo Nordisk CEO to step down - Axios
TipRanks 5d
Novo Nordisk down 5% at $62.93 after CEO resignation announcement

07:42 EDT Novo Nordisk (NVO) down 5% at $62.93 after CEO resignation announcement Published first on TheFly – the ultimate source for real-time, market-moving...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.